astrazeneca-developed variant calling algorithm (AstraZeneca ltd)
90
Structured Review
AstraZeneca ltd
astrazeneca-developed variant calling algorithm
Astrazeneca Developed Variant Calling Algorithm, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/astrazeneca-developed+variant+calling+algorithm/astrazeneca+developed+variant+calling+algorithm/pmc08572452__13045_2021_1196_MOESM2_ESM-37-17-18
Average 90 stars, based on 1 article reviews
Astrazeneca Developed Variant Calling Algorithm, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/astrazeneca-developed+variant+calling+algorithm/astrazeneca+developed+variant+calling+algorithm/pmc08572452__13045_2021_1196_MOESM2_ESM-37-17-18
Average 90 stars, based on 1 article reviews
astrazeneca-developed variant calling algorithm - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Next-Generation Sequencing:Article Title: VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status Article Snippet: The NGS data was aligned and analyzed within the BCBio framework (https://bcbionextgen.readthedocs.org/en/latest/) using an Variant Assay:Article Title: VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status Article Snippet: The NGS data was aligned and analyzed within the BCBio framework (https://bcbionextgen.readthedocs.org/en/latest/) using an |